Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Drug Dosage Regimen: Overview01:15

Drug Dosage Regimen: Overview

3.5K
A drug dosage regimen describes the specific instructions and schedule for administering a drug to a patient. It considers factors such as drug dosage, frequency, route of administration, and duration of treatment. Designing an appropriate dosage regimen for a patient aims to achieve a target drug concentration at the site of action.
Typically, the starting dose and dosing interval are guided by the manufacturer's recommendations based on clinical trials conducted during and after drug...
3.5K
Pharmacovigilance01:19

Pharmacovigilance

786
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
786
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

239
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
239
Drug Administration and Therapy Phases: Overview01:26

Drug Administration and Therapy Phases: Overview

416
Drugs, the chemical agents used in diagnosing, treating, or preventing diseases, undergo a four-phase process of development: pharmaceutic, pharmacokinetics, pharmacodynamics, and therapeutic.
The pharmaceutical phase focuses on leveraging the physicochemical properties of the drug to design and manufacture an effective product. Variants include orally administered tablets or capsules, topical creams or ointments, and parenteral-delivery solutions or emulsions.
The pharmacokinetic phase...
416
Biopharmaceutics and Pharmacokinetics: Overview01:28

Biopharmaceutics and Pharmacokinetics: Overview

1.9K
Understanding drugs, drug products, and their performance in pharmaceutical science is pivotal. Drugs, whether simple molecules or complex compounds, are designed to interact with the body's biological systems to diagnose, treat, or prevent diseases. Drug products include various delivery systems such as tablets, capsules, injections, and inhalers. The performance of these drug products is gauged by their ability to deliver the active ingredient to the desired site of action at the...
1.9K
Nursing Clinical Information System01:27

Nursing Clinical Information System

757
Nursing Clinical Information System (NCIS)
A Nursing Clinical Information System (NCIS) is a specialized type of healthcare information system tailored to meet the unique needs of nursing practice. It incorporates the principles of nursing informatics to streamline information management and improve the quality of care delivery.
Critical attributes of NCIS include:
757

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Hypertension Control in Low-Income Patients.

The New England journal of medicine·2026
Same author

A meta-analysis of the long-term effects of antihypertensive therapy on the risk of major cardiovascular disease across 51 randomized trials.

Nature medicine·2026
Same author

Adverse Effects and Treatment Discontinuation of Blood Pressure-Lowering Drugs and Combinations: A Network Meta-Analysis.

JAMA·2026
Same author

National program for cardiovascular disease and hypertension in primary healthcare: WHO-PEN program initial scale-up in Iran (IraPEN).

BMC cardiovascular disorders·2026
Same author

Pre-emptive <i>DPYD</i> genotyping and fluoropyrimidine dose optimisation: Dose tolerance and survival in cancer patients.

Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners·2026
Same author

Pharmacological blood-pressure lowering for the prevention of cardiovascular disease and death across the full spectrum of chronic kidney disease severity: an individual-participant data meta-analysis.

Lancet (London, England)·2026

相关实验视频

Updated: Jun 12, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K

推:一个全面的药品推系统.

Mariam Zomorodi1, Ismail Ghodsollahee2, Jennifer H Martin3

  • 1Department of Computer Science, Faculty of Computer Science and Telecommunications, Cracow University of Technology, Krakow, Poland.

Artificial intelligence in medicine
|September 22, 2024
PubMed
概括
此摘要是机器生成的。

这项研究开发了一种先进的AI驱动药物推系统,可以显著提高药物推的准确性和灵敏性. 该系统通过分析患者数据,疾病概况和药物相互作用来增强药物发现和患者治疗.

关键词:
药物信息提取 药物信息提取药物推系统是药物推系统.混合推方法是混合推方法.推系统是推系统.

更多相关视频

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging
11:07

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging

Published on: November 24, 2021

2.8K
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

1.9K

相关实验视频

Last Updated: Jun 12, 2025

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System
05:10

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

9.6K
Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging
11:07

Visualizing and Quantifying Pharmaceutical Compounds within Skin using Coherent Raman Scattering Imaging

Published on: November 24, 2021

2.8K
Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia
11:06

Network Pharmacology Prediction and Metabolomics Validation of the Mechanism of Fructus Phyllanthi against Hyperlipidemia

Published on: April 7, 2023

1.9K

科学领域:

  • 人工智能在医学中的应用
  • 计算药理学计算药理学
  • 医疗信息学 医疗信息学

背景情况:

  • 准确的药物推对于有效的患者治疗至关重要,需要复杂的系统.
  • 现有的方法往往缺乏整合各种数据源以提供个性化的建议的能力.

研究的目的:

  • 开发一个高精度的药物推系统,使用全面的数据集.
  • 利用机器学习和自然语言处理来改善对医生和患者的药物建议.

主要方法:

  • 设计了一个医药推系统,将数据库中的患者,疾病和药物特征集成.
  • 采用自然语言处理进行情绪分析和神经网络与推系统算法.
  • 开发了矩阵因子化模型和基于患者数据训练的深度学习模型,结合了药物相互作用规则.

主要成果:

  • 与传统的矩阵因子化相比,拟议的模型在准确度 (26%),灵敏度 (34%) 和命中率 (40%) 中显著改善.
  • 与其他机器学习方法相比,准确度平均提高了31%,灵敏度提高了29%,命中率提高了28%.
  • 该系统成功地推了与现实世界处方一致的可接受药物组合.

结论:

  • 开发的深度学习模型比传统的机器学习和矩阵因子化技术在药物推方面提供了更高的性能.
  • 虽然有希望,但使用更大的数据集可以实现临床准确性和灵敏性的进一步改进.
  • 开源实施促进了人工智能驱动的制药建议的进一步研究和开发.